RO7172508

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO7172508, covering 2020-09-03 to 2020-09-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RO7172508 in Patients With Locally Advanced and/or Metastatic CEA-Positive Solid Tumors [Phase 1]